Showing 12 posts of 87 posts found.

Boehringer Ingelheim

Boehringer to create biosimilars division

September 27, 2011
Research and Development Boehringer, biosimilars

Boehringer Ingelheim is to tap into the growing interest in biosimilars with the creation of a division dedicated to that …

Samsung forges biosimilar venture with Quintiles

March 2, 2011
Manufacturing and Production Quintiles, Samsung, biosimilar production, biosimilars, pharma production

South Korean electronics giant Samsung has formed a joint venture with Quintiles with the objective of breaking into the market …

Merck taps Parexel to help it meet biosimilar ambitions

January 18, 2011
Research and Development Merck & Co, Parexel, biosimilars

Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …


Biosimilars: the great balancing act

April 6, 2010
Research and Development biogenerics, biosimilars

Faced with recessionary pressures, ageing populations, and increasingly expensive therapies, governments are redoubling their efforts to contain healthcare costs. Biologics …

Healthcare reform momentus for pharma too

April 1, 2010
Obama, US, biosimilars, healthcare reform

Historic reforms of America’s healthcare system have now passed into law, representing its most radical overhaul ever. Nevertheless, the bill …

Brennan rejects generics diversification model

February 11, 2010
Sales and Marketing AstraZeneca, biosimilars, em, generics, industry

AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …

FDA to assess Neupogen biosimilar

February 3, 2010
Research and Development, Sales and Marketing Hospira, Teva, biosimilars

US regulator the FDA has agreed to assess Teva’s application for a biosimilar version of Amgen’s Neupogen (filgrastim). XM02, a …

Hospira takes charge of biogeneric Neupogen

October 14, 2009
Sales and Marketing Hospira, biosimilars, generics

US pharmaceutical company Hospira has acquired worldwide rights to a biogeneric version of Amgen's neutropenia treatment Neupogen (filgrastim) in a …

Cipla plans push into biosimilars

September 10, 2009
Sales and Marketing biosimilars, generics

Mumbai-based generics manufacturer Cipla is to begin making biosimilars, generic substitutable versions of branded biologic drugs. It plans to do …

Are biosimilars delivering the goods in the EU?

March 10, 2009
Manufacturing and Production, Research and Development biosimilars

In January, leading pharmaceutical experts attended the 2009 Forum Institute seminar on biosimilars, and the challenges involved in their successful …

Teva and Lonza join forces in biosimilars

January 21, 2009
Sales and Marketing biosimilars, generics

Teva, the world's largest generics manufacturer, has teamed up with manufacturing specialist Lonza to exploit the market for biosimilar medicines. …

Latest news from Datamonitor

November 17, 2008
Sales and Marketing biosimilars, generics

Key decision makers will shape the biosimilars landscapeWith many biologic drugs used to treat increasingly common diseases such as cancer …

Latest content